Results 251 to 260 of about 439,932 (354)
Glycolipid antigen recognition by invariant natural killer T cells and its role in homeostasis and antimicrobial responses [PDF]
Koji Hayashizaki +2 more
openalex +1 more source
This study demonstrates that Mn2⁺–tumor DNA complexes encapsulated in dendritic cell (DC)– derived immunogenic extracellular vesicles (EVDC@Mn‐DNA) act as a DC‐specific cGAS– STING activator. EVDC@Mn‐DNA treatment enhances intratumoral DC activation, improves tumor vascular function, promotes CD8⁺ T cell activity, and suppresses pancreatic tumor growth,
Xue Jiang +13 more
wiley +1 more source
The cell death regulator c-FLIP<sub>R</sub> impairs natural killer cell responses during influenza a virus infection. [PDF]
Carmo-Fernandes A +7 more
europepmc +1 more source
PDAC has a poor prognosis due to chemoresistance. We revealed that MCU upregulation is associated with chemoresistance and stemness in PDAC. MCU‐mediated Ca2+ influx induced ER stress, activating the PERK‐ATF4/NRF2 axis to enhance PSAT1/SLC711 expression and glutathione synthesis, reducing ROS and maintaining stemness.
Zekun Li +17 more
wiley +1 more source
Peptide-specific natural killer cell receptors. [PDF]
Sim MJW, Li B, Long EO.
europepmc +1 more source
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin +6 more
wiley +1 more source
Natural killer cell-based immunotherapies for colorectal cancer: Current strategies, challenges, and future perspectives. [PDF]
Zhang XJ +11 more
europepmc +1 more source
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin +14 more
wiley +1 more source
Assessment of natural killer cell subpopulations in pediatric patients with transfusion-dependent β-thalassemia major. [PDF]
Elbassal FI +4 more
europepmc +1 more source

